QuilliChew ER clinical study results

A clinical study demonstrated that children who took QuilliChew ER® (methylphenidate HCl) had improved attention and behavior when compared to those who took a sugar pill.

The study was performed in a laboratory classroom setting. Teachers and raters used a rating scale (SKAMP) to evaluate the efficacy of QuilliChew ER on attention and behavior in children with ADHD ages 6 to 12 when compared to children taking a sugar pill.

Children taking QuilliChew ER showed improved attention and behavior from 45 minutes to 8 hours after taking when compared with those children who took sugar pills.

In a clinical study, QuilliChew ER improved attention and behavior compared to a sugar pill at 45 minutes, 2, 4, and 8 hours after taking.